Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / Ordinary shares
-
Shares outstanding
-
49,942,911
-
Number of holders
-
83
-
Total 13F shares, excl. options
-
26,369,515
-
Shares change
-
+5,469,901
-
Total reported value, excl. options
-
$1,237,624,033
-
Value change
-
+$261,557,875
-
Put/Call ratio
-
507%
-
Number of buys
-
52
-
Number of sells
-
28
-
Price
-
$46.94
Institutional Holders of Immunocore Holdings plc - Ordinary shares (IMCR) as of Q3 2022
As of 30 Sep 2022 Immunocore Holdings plc - Ordinary shares (IMCR) had 83 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 26,369,515 shares of stock of the company.
Largest 10 holders included RTW INVESTMENTS, LP, Rock Springs Capital Management LP, BAKER BROS. ADVISORS LP, Avidity Partners Management LP, FMR LLC, PRICE T ROWE ASSOCIATES INC /MD/, COWEN AND COMPANY, LLC, GENERAL ATLANTIC, L.P., FIRST MANHATTAN CO, and Paradigm Biocapital Advisors LP.
This table shows 83 institutional shareholders of the security as of 30 Sep 2022.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.